Article
Resected stage I anaplastic lymphoma kinase-positive lung adenocarcinoma has a negative impact on recurrence-free survival.
Thoracic cancer - 1 Apr 2022
Fujibayashi Yusuke, Tane Shinya, Kitazume Mai, Kuroda Sanae, Kimura Kenji, Kitamura Yoshitaka, Nishio Wataru
Abstract excerpt
BACKGROUND: The clinical and prognostic implications of anaplastic lymphoma kinase (ALK) status in resected lung cancers remain unclear. In this study we analyzed the prognostic and predictive significance of ALK-positive among patients with completely resected lung adenocarcinoma. METHODS: We retrospectively reviewed 197 patients with lung adenocarcinoma who underwent complete surgical resection and had been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
